Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
Follow FDA
En Español
Search FDA
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
Pediatric Studies Characteristics - Detail
FDA Home
Pediatrics
Pediatric Studies Characteristics
Detail
-
Please note:
JavaScript must be enabled for this application to work properly.
Check your settings
if you are unsure if your JavaScript is enabled.
Approval Date:
03/26/2008
Trade Name:
Ventolin HFA
Generic or Proper Name (*):
albuterol
Indications Studied:
Treatment of symptoms of bronchospasm associated with obstructive airway disease
Therapeutic Category:
Antiasthmatic
Ages Studied:
birth - less than 4 years
Study #:
1
Study Type:
Efficacy/Safety
Study Design:
Single-Blind/Placebo/Parallel Group
No Patients:
77
No Centers:
37
No Countries:
1
BPCA(B), PREA(P):
B
Asian:
1
Black:
18
Other:
2
White:
42
Native Hawaiian or Pacific Islander:
0
American Indian/Alaska Native:
0
Hispanic/Latino:
14
-
-